Longitude Capital specializes in making venture growth investments in biotechnology and medical technology companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. The Firm's growth strategy is rooted in b...Show all
Phone: 650-854-5700
800 El Camino Real
Suite 220
Menlo Park, 94025
California, United States
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2021-01-07 | LEXEO Therapeutics | Series A | $85M | Invus Group, Janus Henderson Investors, Lundbeckfonden, Omega Fund Management, PBM Capital Group, and Woodline Partners |
2021-01-07 | Endeavor Biomedicines | Series A | $62M | Omega Fund Management |
2020-10-22 | Orbus Therapeutics | Series A - IV | $10M | Abingworth, Adams Street Partners, and H.I.G. BioHealth Partners |
2020-10-06 | Talaris Therapeutics | Series B | $115M | Aisling Capital, BlackRock, Blackstone, Cormorant Asset Management, Eventide Asset Management, Invus Group, Logos Capital, Pamoja Capital, Qiming Venture Partners, Surveyor Capital, and Viking Global Investors |
2020-09-01 | Eargo | Series E - II | $10.58M | Gilde Healthcare Partners, Maveron, New Enterprise Associates, and Pivotal bioVenture Partners |